JP2015532645A5 - - Google Patents

Download PDF

Info

Publication number
JP2015532645A5
JP2015532645A5 JP2015528568A JP2015528568A JP2015532645A5 JP 2015532645 A5 JP2015532645 A5 JP 2015532645A5 JP 2015528568 A JP2015528568 A JP 2015528568A JP 2015528568 A JP2015528568 A JP 2015528568A JP 2015532645 A5 JP2015532645 A5 JP 2015532645A5
Authority
JP
Japan
Prior art keywords
compound
immunogenic carrier
nhc
conjugate
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528568A
Other languages
English (en)
Japanese (ja)
Other versions
JP6171014B2 (ja
JP2015532645A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/055700 external-priority patent/WO2014031587A1/en
Publication of JP2015532645A publication Critical patent/JP2015532645A/ja
Publication of JP2015532645A5 publication Critical patent/JP2015532645A5/ja
Application granted granted Critical
Publication of JP6171014B2 publication Critical patent/JP6171014B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528568A 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン Active JP6171014B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691454P 2012-08-21 2012-08-21
US61/691,454 2012-08-21
PCT/US2013/055700 WO2014031587A1 (en) 2012-08-21 2013-08-20 Haptens of olanzipine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017130471A Division JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン

Publications (3)

Publication Number Publication Date
JP2015532645A JP2015532645A (ja) 2015-11-12
JP2015532645A5 true JP2015532645A5 (OSRAM) 2016-05-26
JP6171014B2 JP6171014B2 (ja) 2017-07-26

Family

ID=49081007

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン
JP2017130471A Active JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017130471A Active JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Country Status (11)

Country Link
US (1) US9303041B2 (OSRAM)
EP (2) EP3492473B1 (OSRAM)
JP (3) JP6171014B2 (OSRAM)
CN (1) CN104854110B (OSRAM)
AU (1) AU2013306018B2 (OSRAM)
CA (1) CA2882454C (OSRAM)
ES (2) ES2701062T3 (OSRAM)
PL (1) PL2888269T3 (OSRAM)
PT (1) PT2888269T (OSRAM)
TR (1) TR201816378T4 (OSRAM)
WO (1) WO2014031587A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3321254T (pt) 2012-08-21 2020-10-20 Janssen Pharmaceutica Nv Haptenos de aripiprazol e seu uso em imunoensaios
PT2888284T (pt) 2012-08-21 2022-11-18 Janssen Pharmaceutica Nv Anticorpos dirigidos contra haptenos de risperidona e a sua utilização
CN104736564B (zh) 2012-08-21 2019-02-05 詹森药业有限公司 喹硫平半抗原的抗体及其用途
ES2701062T3 (es) * 2012-08-21 2019-02-20 Janssen Pharmaceutica Nv Haptenos de olanzapina
EP2888277A4 (en) 2012-08-21 2016-05-18 Ortho Clinical Diagnostics Inc ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF
PT2888593T (pt) 2012-08-21 2018-12-12 Janssen Pharmaceutica Nv Anticorpos contra risperidona e utilizações dos mesmos
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
CA2882595C (en) 2012-08-21 2019-06-04 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine haptens and use thereof
WO2014031662A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine and use thereof
CN110054694B (zh) 2012-08-21 2024-02-20 詹森药业有限公司 阿立哌唑半抗原的抗体及其用途
PL2888592T3 (pl) 2012-08-21 2018-03-30 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
JP6270845B2 (ja) 2012-08-21 2018-01-31 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールに対する抗体及びその使用
JP6994461B2 (ja) 2015-12-17 2022-02-04 ヤンセン ファーマシューティカ エヌ.ベー. クエチアピンに対する抗体及びその使用
WO2017106501A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to risperidone and use thereof
CN110938082A (zh) * 2019-10-30 2020-03-31 杭州博拓生物科技股份有限公司 一种奥氮平人工抗原及其制备方法
CN110950808A (zh) * 2019-10-30 2020-04-03 杭州博拓生物科技股份有限公司 一种氯氮平人工抗原及其制备方法
EP4267187A1 (en) * 2020-12-22 2023-11-01 Intervet International B.V. Conjugated zearalenone to protect against mycotoxicosis
CN114685527B (zh) * 2020-12-25 2024-03-05 长沙博源医疗科技有限公司 一种奥氮平衍生物、免疫原、抗奥氮平特异性抗体及其制备方法与应用
CN114685477B (zh) * 2020-12-25 2023-11-17 长沙博源医疗科技有限公司 一种利奈唑胺衍生物、免疫原、抗利奈唑胺特异性抗体及其制备方法与应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
ES2153373T3 (es) * 1992-05-29 2001-03-01 Lilly Co Eli Derivados de tienobenzodiazepina para el tratamiento de trastornos del sistema nervioso central.
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
DE69323244T2 (de) * 1992-06-26 1999-07-08 Johnson & Johnson Clinical Diagnostics, Inc., Rochester, N.Y. Immunotests unter Verwendung von markierten Thyronin-Analogen
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
JP2005533009A (ja) * 2002-03-28 2005-11-04 イーライ・リリー・アンド・カンパニー ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用
AU2003264915A1 (en) * 2002-08-05 2004-02-25 Eli Lilly And Company Piperazine substituted aryl benzodiazepines
PT1664007E (pt) 2003-09-23 2010-02-15 Fermion Oy Preparação de quetiapina
MX2007002210A (es) * 2004-08-26 2007-05-07 Nicholas Piramal India Ltd Profarmacos que contienen enlazantes bioescindibles novedosos.
TW200616604A (en) * 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
AU2008303540B2 (en) * 2007-09-27 2012-04-26 Novartis Ag Drug monitoring assay
WO2010033270A1 (en) 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
EP2350077B1 (en) 2008-10-14 2016-01-27 Entasis Therapeutics Limited Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
EP2519101B1 (en) 2009-12-31 2015-08-19 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
SI2544536T1 (sl) 2010-03-11 2019-03-29 Kempharm, Inc. Maščobno kislinski konjugati kvetiapina proces za njih izdelavo in uporabo
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
WO2013088255A1 (en) * 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
ES2701062T3 (es) * 2012-08-21 2019-02-20 Janssen Pharmaceutica Nv Haptenos de olanzapina

Similar Documents

Publication Publication Date Title
JP2015532645A5 (OSRAM)
JP2017222671A5 (OSRAM)
JP2015527363A5 (OSRAM)
JP2015181191A5 (OSRAM)
JP2016520672A5 (OSRAM)
JP2018536572A5 (OSRAM)
UA113643C2 (xx) N-цикліламіди як нематоциди
JP2013032389A5 (OSRAM)
WO2015008218A3 (en) Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
JP2015523910A5 (OSRAM)
CY1121484T1 (el) Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
WO2015051079A3 (en) Phosphohistidine mimetics and antibodies to same
SA518391413B1 (ar) عملية تحضير وتبلر لليوزيمينول
JP2012250569A5 (OSRAM)
WO2016005943A8 (en) Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy- cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs
WO2015128882A3 (en) Crystalline forms of n-(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide and process for the preparation thereof
EA201491463A1 (ru) Способ получения соединения по новой реакции присоединения михаэля с применением воды или различных кислот в качестве добавки
JP2017115098A5 (OSRAM)
BR112015021072A2 (pt) processo de preparação de um monotriflato de isohexídeo, composto químico, processo para fabricação de um composto derivado de um monotriflato de isohexídeo, e, composto derivado
SE0701694L (sv) Nya bronkdilaterande a,b-omättade amider
PH12016501808A1 (en) Chemical compounds
JP2018531301A5 (OSRAM)
EP3272734A8 (en) Ahu377 crystal form, preparation method and use thereof